CIGB-300, a synthetic peptide-based drug that targets the CK2 phosphoaceptor domain. Translational and clinical research
Silvio E. Perea, Idania Baladron, Yanelda Garcia, Yasser Perera, Adlin Lopez, Jorge L. Soriano, Noyde Batista, Aley Palau, Ignacio Hernández, Hernán Farina, Idrian Garcia, Lidia Gonzalez, Jeovanis GilТом:
356
Мова:
english
Сторінки:
6
DOI:
10.1007/s11010-011-0950-y
Date:
October, 2011
Файл:
PDF, 310 KB
english, 2011